East Metropolitan Health Service, Australia
1 clinical trials · Sponsor
◉ Watch East Metropolitan Health Service, Australia
| Record | Firm | Date |
|---|---|---|
| A Phase II Trial of Tumour Infiltrating Lymphocyte Adoptive Cell Therapy in Patients With Immune Checkpoint Inhibitor Resistant Unresectable or Metastatic Melanoma (NCT07651618) | East Metropolitan Health Service, Australia | 2026-07-01 |
Track East Metropolitan Health Service, Australia automatically
Every clearance here is in the API, with alerts when new ones post.